Evaluation of ambrein and epicoprostanol for their antioxidant properties: Protection against adriamycin-induced free radical toxicity

Food and Chemical Toxicology

Volumn 45, Issue 9, 2007, Pages 1614-1619

  Raza, Muhammad ^a   Alorainy, Mohammad S ^a   Alghasham, Abdullah A ^a  

^a QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Adriamycin; Ambrein; Antioxidant; Chemiluminescence; Epicoprostanol; Free radicals; Glutathione; Malondialdehyde

Indexed keywords

AMBREIN; DOXORUBICIN; EPICOPROSTEROL; FREE RADICAL; GLUTATHIONE; LIPID PEROXIDE; MALONALDEHYDE; STEROL DERIVATIVE; THIOL DERIVATIVE; TRITERPENOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN;

AMBERGRIS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; CHEMILUMINESCENT MEASUREMENTS; CHOLESTANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FREE RADICALS; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; MICE; NAPHTHOLS; TRITERPENES;

ANIMALIA; MUS; RATTUS;

EID: 34547096988     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.02.024     Document Type: Article

References (33)

1. Al-Gozech K. Prophet Medicine. second ed. (1981), Al-Resala Publishers, Syria p. 340
2. Allen R.C., and Loose L.D. Phagocytosis of luminol-dependant chemiluminescence in rat alveolar and peritoneal macrophages. Biochem. Biophys. Res. Commun. 69 (1976) 245-252
3. Benton W. Encyclopedia Britannica vol. 1 (1963), Encyclopedia Britannica, Inc, Chicago p. 718
4. Cambie R.C. Perfumes related to ambergris. Chemistry and Industry in New Zealand 3 (1967) 4-8
5. Dannenfeldt K.H. Ambergris: the search for its origin. Isis 73 (1982) 382-397
6. Epstein W.L. In: Funa T.E., and Ballauca N. (Eds). Report to RIFM Fenarolis Handbook of Flavour Ingredients. second ed. vol. 1 (1975), CRC Press, Cleveland 273
7. Griffin-Green E.A., Zaleska M.M., and Erecinska M. Adriamycin-induced lipid peroxidation in mitochondria and microsomes. Biochem. Pharmacol. 15 16 (1988) 3071-3077 37
8. Lawrence B.M. Progress in essential oils. Perfumer Flavorist. 8 (1983) 61-62
9. Mookherjee, B.D., Patel, R.R., 1977. Isolation and identification of volatile constituents of tincture ambergris. Paper No. 137, In: 7th International Congress of Essential Oils, Kyoto, Japan, pp. 479-481.
10. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
11. Ohloff G. In: Ernst T.T. (Ed). The Fragrance of Ambergris (1982), Academic Press, New York 535-573
12. Powell S.R., and McCay P.B. Inhibition of doxorubicin -initiated membrane damage by N-acetylcysteine: possible mediation by a thiol-dependent, cytosolic inhibitor of lipid peroxidation. Toxicol. Appl. Pharmacol. 96 2 (1988) 175-184
13. Quiles J.L., Huertas J.R., Battino M., Mataix J., and Ramírez-Tortosa M.C. Antioxidant nutrients and adriamycin toxicity. Toxicology 180 (2002) 79-95
14. Raza M., Al-Bekairi A.M., Ageel A.M., and Qureshi S. Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: time dependence of peroxidative injury. Pharmacol. Res. 35 2 (1997) 153-157
15. Raza M., Taha S.A., and El-Khawad I.E. Studies on the cardiovascular effects of ambrein pretreatment in rats. Nat. Prod. Sci. 5 1 (1999) 25-32
16. Sadzuka Y., Sugiyama T., Shimoi K., Kinae N., and Hirota S. Protective effect of flavonoids on doxorubicin-induced cardiotoxicity. Toxicol. Lett. 16 1 (1997) 1-7 92
17. Sadzuka Y., and Takino Y. Effect of seasonal variation on lipid peroxide level and glutathione peroxidase activity in the mouse before and after adriamycin administration. Toxicol. Lett. 61 1 (1992) 49-56
18. Sedlak J., and Lindsay R.H. Estimation of total, protein bound and non-protein sulfhydryl groups in tissue with Elman's reagent. Anal. Biochem. 25 (1968) 192-205
19. Suzuki K., Murtuza B., Suzuki N., Smolenski R.T., and Yacoub M.H. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circ. I (2001) 213-217
20. Taha S.A. General pharmacological screening on ambergris extract. Pak. J. Pharmacol. 6 (1989) 75-88
21. Taha S.A., and Rashid S. Preliminary investigations on cardiovascular profile of ambrein. Pak. J. Pharmacol. 7 (1990) 95-100
22. Taha S.A. Effect of ambrein on blood glucose levels of rats. J. Ethnopharmacol. 35 (1991) 145-148
23. Taha S.A. Studies on the mode of action of ambrein as a new antinociceptive compound. Jpn. J. Pharmacol. 60 (1992) 67-71
24. Taha S.A., and Ginawi O.T. Ambrein, the major constituent of ambergris, inhibits oedema responses to carrageenin and serotonin in the rat paw. Bull. Faculty Pharmacy, Cairo University 31 1 (1993) 113-114
25. Taha S.A., and Islam M.W. Effect of ambrein, a major constituent of ambergris, on some hormonal levels in normal Wistar rats. Saudi Pharma. J. 2 4 (1994) 174-178
26. Taha S.A., Raza M., Gader A.G.M.A., and Hafeez M.A. A study of ambrein treatment for the evaluation of change in plasma biochemical parameters in rats. Jpn. J. Pharmacol. 67 (1995) 205-209
27. Taha S.A., El-Olemy M.M., and Raza M. Evaluation of epicoprostanol: a major sterol of ambergris for anti-inflammatory and antipyretic activities. Pak. J. Pharmacol. 11 2 (1995) 65-72
28. Taha S.A., and Raza M. Protection by epicoprostanol against hyperglycemia and insulitis in normal and diabetic rats. J. Ethnopharmacol. 50 (1996) 85-90
29. Taha, S.A., Raza, M., 1997. A study of epicoprostanol treatment for the evaluation of change in plasma biochemical parameters in rats. In: Ahmad, S.A., Ahmed, S.P.(Eds.), Proceedings of the 2nd Biennial Conference on Pharmacology and Therapeutics, pp. 119-135.
30. Taha S.A., Raza M., and El-Khawad I.E. Effect of ambrein on smooth muscle responses to various agonists. J. Ethnopharmacol. 60 (1998) 19-26
31. The Merck Index, 1968. An Encyclopedia of Chemicals and Drugs, eighth ed. p. 49, Merck and Co. Inc., Rahway.
32. The Merck Index, 12th ed. on CD-ROM, Version 12:3, 2000. Co-Published by Chapman & Hall/CRC, 2000 NW Corporate Blvd, Boca Raton, FL 33431 USA and Merck and Co., Inc., Whitehouse Station NJ, USA.
33. Tono-Oka T., Ueno N., Matsumoto T., Ohkawa M., and Matsumoto S. Chemiluminescence of whole blood. I. A simple and rapid method for the estimation of phagocytic function of granulocytes and opsonic activity in whole blood. Clin. Immunopathol. 26 (1983) 66-75